Controlled transdermal administration of melatonin
    5.
    发明授权
    Controlled transdermal administration of melatonin 失效
    控制透皮给药褪黑激素

    公开(公告)号:US5508039A

    公开(公告)日:1996-04-16

    申请号:US211786

    申请日:1994-06-13

    摘要: The present invention is directed to the transdermal administration of melatonin together with a suitable permeation enhancer. The invention includes a transdermal drug delivery device (10) comprising a matrix (12) adapted to be placed in melatonin- and permeation enhancer-transmitting relation with the skin site (18). The matrix (12) contains sufficient amounts of a permeation enhancer and of melatonin, in combination, to continuously administer to the skin (18) for a predetermined period of time the melatonin to provide an effective therapeutic result. The invention is also directed to a method for the transdermal administration of a therapeutically effective amount of melatonin together with a skin permeation-enhancing amount of a suitable permeation enhancer. The invention further includes methods for time- and rate-patterned transdermal delivery of melatonin to simulate the natural circadian rhythmic profile of melatonin in mammals.

    摘要翻译: PCT No.PCT / US92 / 08919 Sec。 371日期1994年6月13日 102(e)日期1994年6月13日PCT提交于1992年10月16日PCT出版社 出版物WO93 / 07870 日期:1993年04月29日。本发明涉及褪黑激素与合适的渗透促进剂的透皮给药。 本发明包括透皮药物递送装置(10),其包括适于与皮肤部位(18)放置在与褪黑激素和渗透增强剂 - 传递关系中的基质(12)。 基质(12)含有足够量的渗透促进剂和褪黑激素组合,以连续给予皮肤(18)一段预定的时间,以提供有效的治疗结果。 本发明还涉及一种用于透皮施用治疗有效量的褪黑激素以及皮肤渗透增强量的合适的渗透增强剂的方法。 本发明还包括用于对褪黑激素进行时间和速率图案化的透皮递送以模拟哺乳动物中褪黑激素的天然昼夜节律谱的方法。